. 2018 Sep 10;19:484. doi: 10.1186/s13063-018-2864-4

Table 2.

Schedule for assessment

Outcome measures	Screening	Baseline	Treatment (weeks 1–8)		Follow-up (weeks 9–16)
Outcome measures	Screening		Week 4	Week 8	Week 12	Week 16
VAS for lower back pain	◎	◎	◎	◎	◎	◎
VAS for radiating pain		◎	◎	◎	◎	◎
ODI		◎	◎	◎	◎	◎
RMDQ		◎	◎	◎	◎	◎
EQ-5D-5 L		◎	◎	◎	◎	◎
GPE			◎	◎	◎	◎
Assessment of binding						◎
Adverse events^a		◎	◎	◎	◎	◎

^aAdverse event will be monitored throughout the study period

VAS visual analogue scale, ODI Oswestry Disability Index, RMDQ Roland-Morris disability questionnaire, EQ-5D-5 L EuroQol 5 Dimensions 5 Levels, GPE global perceived effect